David Moore

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 868 citations

Placebo-controlled Phase 3, Neuropharmacology, Pharmacotherapy +4

Adjunctive perampanel for refractory partial-onset seizures

Jacqueline A. French, Gregory L. Krauss, Victor Biton et al. · Neurology · 2012 · 470 citations · Full text

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.

Nicola Peel, David Moore, N.A. Barrington et al. · Annals of the Rheumatic Diseases · 1995 · 378 citations · Full text

The use of faecal microbiota transplant as treatment for recurrent or refractory<i>Clostridium difficile</i>infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan Segal et al. · Gut · 2018 · 322 citations · Full text

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome

Daniel L. Worthley, Kerry Phillips, Nicci Wayte et al. · Gut · 2011 · 293 citations